October 10, 2014 / 2:15 PM / 5 years ago

BRIEF-Meda completes Rottapharm buy, launches 2 bln SEK rights issue

STOCKHOLM, Oct 10 (Reuters) - Meda Ab :

* Complete terms and conditions of the rights issue, including subscription price, are expected to be announced no later than 6 November 2014. Subject to the approval of the rights issue by the Extraordinary General Meeting, the subscription period will run from 19 November up to and including 4 December 2014.

* The purpose of the rights issue is to finance part of the acquisition of Rottapharm. Further company coverage: (Reporting by Stockholm newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below